Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> Posts navigation Newer posts